| Primary information |
|---|
| sequence ID | Seq_7179 |
| Peptide sequence | SHALQLNN |
| CancerPDF_ID | CancerPDF_ID1916, CancerPDF_ID3157, CancerPDF_ID8559, CancerPDF_ID9614, |
| PMID | 21136997,21136997,23667664,21533267 |
| Protein Name | Complement C4-B,Complement C4-A,Complement C3f,Complement C4-A |
| UniprotKB Entry Name | CO4B_HUMAN,CO4A_HUMAN,CO3_HUMAN,CO4A_HUMAN |
| Fluid | Serum,Plasma,Serum,Serum |
| M/Z | 895.45118,895.4512,895.45,448.72 |
| Charge | 1,1,1,2 |
| Mass (in Da) | NA,NA,896.98,NA |
| fdr | NA,NA,NA,NA |
| Profiling Technique | LC-MS,LC-MS,MALDI-TOF,LC-MS |
| Peptide Identification technique | LC-MS-MS/MS,LC-MS-MS/MS,FT-ICR MS/MS + nano-HPLC,LC/MS/MS |
| Quantification Technique | LC-ESI-MS,LC-ESI-MS,NA,Multiple Reaction Monitoring |
| Labelled/Label Free | Label Free,Label Free,Label Free,Label Free |
| FDR | NA,NA,NA,1.49 |
| CancerPDF_ID | CancerPDF_ID1916, CancerPDF_ID3157, CancerPDF_ID8559, CancerPDF_ID9614, |
| p-Value | NA,NA,NA,NA |
| Software | MASCOT(v. 2.2.01),MASCOT(v. 2.2.01),MASCOT,MASCOT |
| Length | 8,8,8,8 |
| Cancer Type | Colorectal cancer,Normal,"Breast cancer, Lung cancer, Rectal cancer",Lung adenocarcinoma |
| Database | SwissProt Database,SwissProt Database,NA,Swissprot Database (57.4) |
| Modification | NA,NA,NA,NA |
| Number of Patients | 30 patients and 30 healthy controls,27 healthy individuals,"Breast Cancer =84, lung cancer= 70, Rectal cancer = 30patients; 500 healthy",62 lung adenocarcinoma and 30 healthy control |
| Regulation | NA,NA,NA,"Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" |
| Validation | Leave One out Cross validation,Leave One out Cross validation,NA,MRM-based validation of 19 candidates |
| Sensitivity | NA,NA,NA,NA |
| Specificity | NA,NA,NA,NA |
| Accuracy | NA,NA,NA,NA |
| Peptide Atlas | NA |
| IEDB | |